| No. | Injections | p53 genotype | TCR | Vα/Vδ chaina | Vß/Vγ chaina | Co-receptor | CD1d-tetramer bindingb | PLZFb |
|---|---|---|---|---|---|---|---|---|
| 1 | PBS | −/− | αβ | iVα14 | Vβ8.2 | DN | + | + |
| 2 | PBS | −/− | αβ | iVα14 | Vβ7 | DN | + | + |
| 3 | PBS | −/− | αβ | iVα14 | Vβ7 | DN | n.d. | n.d. |
| 4 | PBS | −/− | αβ | iVα14 | Vβ7 | DN | + | + |
| 5 | PBS | −/− | αβ | iVα14 | Vβ7 | CD8lo | n.d. | n.d. |
| 6 | Spn | −/− | αβ | iVα14 | Vβ8.2 | CD8lo | + | + |
| 7 | Spn | −/− | αβ | iVα14 | Vβ8.3 | DN | + | + |
| 8 | Spn | −/− | αβ | iVα14 | Vβ7 | DN | n.d. | n.d. |
| 9 | Spn | −/− | αβ | iVα14 | Vβ8.2 | CD8lo | n.d. | n.d. |
| 10 | Spn | −/− | αβ | iVα14 | Vβ8.2 | CD8lo | n.d. | n.d. |
| 11 | Spn | −/− | αβ | iVα14 | Vβ8.2 | CD8lo | + | + |
| 12 | Spn | −/− | αβ | iVα14 | Vβ8 | CD4 | + | + |
| 13 | Spn | +/− | αβ | iVα14 | Vβ8.3 | DN | + | + |
| 14 | Spn | −/− | γδ | Vδ6.3 | Vγ1.1 | DN | − | + |
| 15 | Spn | −/− | γδ | Vδ6.3 | Vγ1.1 | DN | − | + |
| 16 | Spn | +/- | γδ | Vδ6.3 | Vγ1.1 | DN | n.d. | n.d. |
| 17 | E. coli | −/− | αβ | iVα14 | n.d. | DN | + | n.d. |
| 18 | E. coli | −/− | αβ | iVα14 | n.d. | CD8lo | + | n.d. |
| 19 | E. coli | −/− | αβ | iVα14 | n.d. | CD8lo | + | n.d. |
| 20 | E. coli | −/− | αβ | iVα14 | n.d. | DN | + | n.d. |
| 21 | E. coli | −/− | αβ | iVα14 | n.d. | DN | + | n.d. |
| 22 | E. coli | −/− | αβ | iVα14 | n.d. | DN | + | n.d. |
| 23 | E. coli | −/− | αβ | iVα14 | n.d. | CD4 | + | n.d. |
| 24 | E. coli | −/− | αβ | iVα14 | n.d. | DN | + | n.d. |
| 25 | E. coli | −/− | αβ | iVα14 | n.d. | CD8lo | + | n.d. |
| 26 | E. coli | −/− | αβ | iVα14 | n.d. | n.d. | + | n.d. |
| 27 | E. coli | −/− | αβ | iVα14 | n.d. | n.d. | + | n.d. |
| 28 | E. coli | −/− | γδ | Vδ6.3 | Vγ1.1 | DN | − | n.d. |
| No. | Injections | p53 genotype | TCR | Vα/Vδ chain | Vß/Vγ chain | Co-receptor | CD1d-tetramer binding | PLZF |
|---|---|---|---|---|---|---|---|---|
| 1 | PBS | −/− | αβ | iVα14 | Vβ8.2 | DN | + | + |
| 2 | PBS | −/− | αβ | iVα14 | Vβ7 | DN | + | + |
| 3 | PBS | −/− | αβ | iVα14 | Vβ7 | DN | n.d. | n.d. |
| 4 | PBS | −/− | αβ | iVα14 | Vβ7 | DN | + | + |
| 5 | PBS | −/− | αβ | iVα14 | Vβ7 | CD8lo | n.d. | n.d. |
| 6 | −/− | αβ | iVα14 | Vβ8.2 | CD8lo | + | + | |
| 7 | −/− | αβ | iVα14 | Vβ8.3 | DN | + | + | |
| 8 | −/− | αβ | iVα14 | Vβ7 | DN | n.d. | n.d. | |
| 9 | −/− | αβ | iVα14 | Vβ8.2 | CD8lo | n.d. | n.d. | |
| 10 | −/− | αβ | iVα14 | Vβ8.2 | CD8lo | n.d. | n.d. | |
| 11 | −/− | αβ | iVα14 | Vβ8.2 | CD8lo | + | + | |
| 12 | −/− | αβ | iVα14 | Vβ8 | CD4 | + | + | |
| 13 | +/− | αβ | iVα14 | Vβ8.3 | DN | + | + | |
| 14 | −/− | γδ | Vδ6.3 | Vγ1.1 | DN | − | + | |
| 15 | −/− | γδ | Vδ6.3 | Vγ1.1 | DN | − | + | |
| 16 | +/- | γδ | Vδ6.3 | Vγ1.1 | DN | n.d. | n.d. | |
| 17 | −/− | αβ | iVα14 | n.d. | DN | + | n.d. | |
| 18 | −/− | αβ | iVα14 | n.d. | CD8lo | + | n.d. | |
| 19 | −/− | αβ | iVα14 | n.d. | CD8lo | + | n.d. | |
| 20 | −/− | αβ | iVα14 | n.d. | DN | + | n.d. | |
| 21 | −/− | αβ | iVα14 | n.d. | DN | + | n.d. | |
| 22 | −/− | αβ | iVα14 | n.d. | DN | + | n.d. | |
| 23 | −/− | αβ | iVα14 | n.d. | CD4 | + | n.d. | |
| 24 | −/− | αβ | iVα14 | n.d. | DN | + | n.d. | |
| 25 | −/− | αβ | iVα14 | n.d. | CD8lo | + | n.d. | |
| 26 | −/− | αβ | iVα14 | n.d. | n.d. | + | n.d. | |
| 27 | −/− | αβ | iVα14 | n.d. | n.d. | + | n.d. | |
| 28 | −/− | γδ | Vδ6.3 | Vγ1.1 | DN | − | n.d. |
Vα/Vγ and Vß/Vδ chains were determined using either antibody staining and flow cytometry analysis or RT-PCR and nucleotide sequencing of CDR3; iVα14 corresponds to the invariant Vα14 described in iNKT cells.
Assessed by flow cytometry analysis, after fixation and permeabilization for PLZF intracellular staining.
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.